Quality Metrics & Outcome Assessment Flashcards
7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Quality Metrics & Outcome Assessment flashcards as text
A pharmacy's Part D plan reports a medication adherence triple-weighted star measure. This weighting means that:
Answer: The measure is counted three times in calculating the overall star rating
Triple-weighted measures count three times in the overall star calculation, making adherence measures among the most influential on a plan's composite rating.
An MTM program measures 'all-cause 30-day hospital readmissions.' The primary limitation of this metric for assessing MTM impact is:
Answer: Many readmissions are unrelated to medication-related problems MTM can address
All-cause readmissions include admissions for trauma, surgery, or conditions unrelated to medication management, diluting the signal attributable to MTM interventions.
In a run chart used to track monthly MTM CMR completion rates, a 'signal' indicating a non-random shift is defined as:
Answer: Six or more consecutive data points on the same side of the median
Run chart rules define a signal (non-random pattern) as six or more consecutive points on the same side of the median, suggesting a true process change.
The Ambulatory Care Quality Alliance (AQA) pharmacy quality measures focus primarily on:
Answer: Ambulatory prescription appropriateness and adherence
AQA pharmacy quality measures are designed to assess appropriate prescribing, safety, and adherence in ambulatory outpatient settings.
A pharmacist calculates that 65% of her MTM patients achieved their LDL-C goal of <70 mg/dL after 6 months. This is an example of which type of outcome?
Answer: Intermediate clinical outcome
LDL-C is a biomarker (surrogate endpoint) that represents an intermediate clinical outcome, sitting between process (statin use) and true clinical events (MI, stroke).
When an MTM pharmacist identifies a drug-drug interaction between warfarin and fluconazole and recommends dose adjustment, the resulting quality metric most directly affected is:
Answer: Drug-drug interaction resolution rate
Identifying and resolving drug-drug interactions is directly captured by drug-drug interaction resolution rate, a core MTM process and safety quality metric.
Which NCQA HEDIS measure specifically addresses appropriate medication management in patients with asthma?
Answer: Medication Management for People with Asthma (MMA)
HEDIS Medication Management for People with Asthma (MMA) measures the percentage of members with persistent asthma who were dispensed appropriate controller medications.